OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway
Ziyi Wang, Zhe Guo, Xuesong Wang, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 3958-3958
Open Access | Times Cited: 11
Ziyi Wang, Zhe Guo, Xuesong Wang, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 3958-3958
Open Access | Times Cited: 11
Showing 11 citing articles:
Lymphopenia in sepsis: a narrative review
Zhibin Wang, Wenzhao Zhang, Linlin Chen, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 8
Zhibin Wang, Wenzhao Zhang, Linlin Chen, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 8
The pharmacological and biological importance of EZH2 signaling in lung cancer
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 13
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 13
Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
Linxiang Zhang, Xueying Zhang, Yanbin Shi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Linxiang Zhang, Xueying Zhang, Yanbin Shi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Immunoexpressions of PD-L1 and EZH2 in Endometrial Carcinoma: Associations with Clinicopathological Parameters
Badrul Iskandar Abdul Wahab, Shamsul Azhar Shah, Roslina Mohd Arshad, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 1042-1042
Open Access
Badrul Iskandar Abdul Wahab, Shamsul Azhar Shah, Roslina Mohd Arshad, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 1042-1042
Open Access
The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways
Yu Chen, De-zhi Guo, Cheng‐long Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Yu Chen, De-zhi Guo, Cheng‐long Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Epigenetic mechanism of EZH2‐mediated histone methylation modification in regulating ferroptosis of alveolar epithelial cells in sepsis‐induced acute lung injury
Ying Dai, Jiebin Chen, Qingning Duan
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 2
Ying Dai, Jiebin Chen, Qingning Duan
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 2
Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
Zhaoyun Liu, Yue Jia, Chun Yang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8603-8603
Open Access | Times Cited: 4
Zhaoyun Liu, Yue Jia, Chun Yang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8603-8603
Open Access | Times Cited: 4
Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression
Fan Zhang, Shuai Han
International Immunopharmacology (2024) Vol. 142, pp. 113172-113172
Closed Access | Times Cited: 1
Fan Zhang, Shuai Han
International Immunopharmacology (2024) Vol. 142, pp. 113172-113172
Closed Access | Times Cited: 1
Novel insights into the dynamic function of PRC2 in innate immunity
Rosalie W.M. Kempkes, Rab K. Prinjha, Menno P.J. de Winther, et al.
Trends in Immunology (2024)
Open Access | Times Cited: 1
Rosalie W.M. Kempkes, Rab K. Prinjha, Menno P.J. de Winther, et al.
Trends in Immunology (2024)
Open Access | Times Cited: 1
Identification of potential diagnostic biomarkers and therapeutic targets in patients with hypoxia pulmonary hypertension
Hongyan Li, Yi Liu, Hongli Zhang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113028-113028
Closed Access
Hongyan Li, Yi Liu, Hongli Zhang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113028-113028
Closed Access
